Access. Intelligence. Excellence

Advanced Search

Home > Press Room > Press Releases

Press Releases

We invite you to browse through our recent press releases.

For more information Contact Cameron Tew email:ctew@best-in-class.com

Select Year:

Select Month:

2017

At Decade Mark, how are Pharmaceutical Companies Successfully Executing Risk Evaluation and Mitigation Strategies Programs?

It has been 10 years since the U.S. Food and Drug Administration gained the authority to require pharmaceutical companies to develop Risk Evaluation and Mitigation Strategies (REMS) for products that may have safety issues. Given the complexity of balancing regulatory requirements and commercial objectives, research and consulting leader Best Practices, LLC conducted a research project to examine how leading life sciences companies develop and execute successful REMS plans for newly-approved drugs in the U.S.
more ...

Trends in Pharmaceutical Industry Digital Marketing Innovation Highlighted in New Report

Elite healthcare organizations are investing more than ever in digital marketing to learn about their customers, build better relationships, leverage effective online media, and grow revenue. To be successful, companies must continue to innovate and identify the right channels, tools and approaches to reach physicians, patients and other customer groups. But picking the optimal "digital innovation path" is different for every organization.
more ...

Top Medical Affairs Executives to Discuss Medical Affairs Role in Using Real World Data

Research and benchmarking firm Best Practices, LLC will host its next Medical Affairs Roundtable on Thursday, July 20 to discuss how Medical Affairs groups can better integrate Real World Data use into their internal and external work.
more ...

New Marketing Career Path Study Delivers Road Map for Producing Future Company Leaders in Pharmaceutical Industry

In the last decade, the pharmaceutical industry has witnessed the evolution of the marketing function and how companies use marketing to effectively position their treatments for market entry and throughout the product lifecycle. Yet many pharma companies fail to define a clear career path for their high-potential marketers - the company's future leaders.
more ...

New Oncology Launch Study Probes the Investment and Staffing Levels Needed to Successfully Launch a Cancer Drug in the United States

New cancer therapies continue to make their way through the development and approval process in the United States as part of the oncology therapeutic area's resurgence. But the variety of cancer product types – single indication versus second indication - make it challenging for new product launch leaders to ascertain efficient staffing and investment levels for the launch-related activities of their new oncology products.
more ...

Study by Best Practices, LLC Explores How the Pharmaceutical Industry is Utilizing the Role of Medical Affairs to Enhance Payer Interactions

Pharmaceutical companies depend on their relationships with payers to gain formulary access for their products. With payers laying greater emphasis on patient outcomes and economic value, many pharma organizations have turned to their medical affairs function to effectively interact with payers regarding their product's medical information.
more ...

Transparency and Authenticity is Key to a Successful Pharmaceutical Industry Collaboration with Patient Advocacy Groups

Pharmaceutical industry collaborations with patient advocacy groups are an important way for helping brands connect with patients throughout the product lifecycle. In order to identify effective practices in patient advocacy group collaboration and relationship management, Best Practices, LLC undertook benchmarking research.
more ...

Outcomes-Oriented Marketplace Pushing Pharmaceutical Industry to Adjust Roles within Field-Based Medical Teams

Field-based medical teams within pharmaceutical organizations need focused strategies and appropriate resources to meet the growing information needs of physicians, patients and payers. In particular, pharma is adjusting its field-based medical teams to ensure they have the right people to provide the value-oriented and outcomes information that payers need to sign formulary contracts.
more ...

Using Scientific Publications Strategy to Ensure a Pharmaceutical Company's Credibility and a Product's Viability

Scientific publications remain the principal way that biopharmaceutical organizations relay critical clinical trial data to key external stakeholders such as physicians and payers. Data from different phases of drug development are the earliest ways these stakeholders learn about new products and the information serves as the building blocks for how a new product will be positioned in the marketplace.
more ...

Improving New Pharmaceutical Product Launch Results through Effective Preparation of District Sales Managers

While an effective sales force is integral to a successful product launch in the biopharmaceutical industry, it is the district sales manager who plays a key role in reps' performance in the field. Realizing this, savvy pharmaceutical companies are beginning to focus more attention on preparing and measuring performance of the front-line District Sales Managers (DMs) – the leaders who oversee launch-related sales activities in the field.
more ...

Current Trends in How the Pharmaceutical Industry Conducts Disease State Awareness Campaigns is Focus of Research Study

Disease state awareness campaigns are one of the few ways to inform patients and physicians before a product is approved. In essence, they set the table for future marketing efforts at product launch and post-launch.
more ...

Regional New Product Planning Teams Key to Local Market Success with Product Launches in Pharmaceutical Industry

Global teams may call the shots for new product development in pharmaceutical companies, but it is the regional team's insights that can make or break a product's launch in key local markets.
more ...

New Study Focuses on Creating a Value-Oriented Competitive Intelligence Function within a Pharmaceutical Company

The Competitive Intelligence (CI) function is often undervalued in the pharmaceutical industry, and as a result leaders of this role sometimes struggle for attention and resources. The value of the function remains murky in many companies, in part because CI remains a sub-function or a fragmented work group as opposed to a traditional corporate function, such as marketing or sales, according to new research from research and consulting leader Best Practices, LLC.
more ...

New Report Highlights the Benefits and Disadvantages of Utilizing a Contract Sales Organization in the Pharmaceutical Industry

As pharmaceutical companies explore different sales models to improve efficiency and/or meet budget needs, one of the options is a Contract Sales Organization (CSO). While a CSO may save money, it also comes with challenges and disadvantages. Commercial and sales leaders need to consider a host of issues when determining the appropriate fit of a CSO for their current business issue, as well as what are the best CSO vendors to use, and what are the resource expectations.
more ...

Pharmaceutical Data Dissemination Policies Vary Around the World but Off-Label Discussions Typically Only Occur Reactively, New Study Finds

With the shift toward evidence-based medicine and value-based pricing in the marketplace, pharmaceutical companies are turning to their Medical Affairs function to create effective guidelines for the dissemination of critical product information to external stakeholders. And in today's regulatory environment these guidelines are a vital part of ensuring compliance and consistency around on-label and off-label data discussions by global field medical teams.
more ...

New Study Finds that Timing of Brand Activities is a Key Component of an Effective Global Branding Process for New Pharmaceutical Products

Pharmaceutical companies struggle to create global branding that will work across geographies and affiliates. The timing of brand activities is a key component of an effective global branding process that will work across geographies and affiliates, according to new research from consulting firm Best Practices, LLC.
more ...

New Study Highlights Strategies for Developing Strong Medical Information Groups in Pharmaceutical Companies

Medical information groups within the pharmaceutical sector are exploring ways to increase their self-service capabilities to manage inquiries from external stakeholders such as Health Care Providers (HCPs). New research from consulting leader Best Practices, LLC found that many pharma organizations have developed self-service website portals where HCPs can sign on and ask questions electronically.
more ...

Current Practices in Pharmaceutical Advisory Board Management are Highlighted in New Report

Pharmaceutical companies have long used advisory boards to gain commercial and medical insights about products either in development or already on the market. But new Sunshine Act reporting requirements have forced the pharma industry to alter how it manages advisory board meetings.
more ...

Study Highlights Keys to Creating a High-Value Medical Affairs Function in a Changing Healthcare Environment

Within the pharmaceutical industry, the medical affairs function carries heavy responsibilities because of its accountability across areas such as clinical development, thought leader management and medical liaison oversight.
more ...

ACCESS AND INTELLIGENCE FOR ACHIEVING WORLD-CLASS EXCELLENCE

Quick Links

About Us | Contact Us | Faq | Share Your Suggestion | Sitemap

All contents copyright 1998-2020 Best Practices, LLC (919) 403-0251
Read our Terms and Conditions of Use, Privacy Policy and Copyright Information